Several studies have shown that adiponectin expression or production by EAT is decreased in patients with coronary artery disease (CAD) [51,52,53,54,55], metabolic syndrome [56] or T2D [57]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.